期刊文献+

慢性心力衰竭患者外周血白介素-27与树突状细胞亚群变化的研究 被引量:5

Changes in the Levels of IL-27 and dendritic cell sub-population in peripheral blood of patients with chronic heart failure
原文传递
导出
摘要 目的探讨白介素-27(IL-27)、树突状细胞(dendritic cells,DCs)在慢性心力衰竭患者外周血中的表达变化。方法选取2012年6月至2013年12月入住南方医科大学珠江医院心血管内科的慢性心力衰竭患者96例,根据纽约心功能分级,分为纽约心功能(NYHA) Ⅳ级组、NYHA Ⅲ级组、NYHA Ⅱ级组以及NYHAⅠ级组,心脏超声检测心功能变化,流式细胞术检测外周血DCs亚群比例和计数,ELISA法检测外周血IL-27、BNP的表达。结果 NYHA Ⅰ级组、NYHA Ⅱ级组、NYHA Ⅲ级组、NYHA Ⅳ级组,IL-27浓度呈依次递减(P<0.05),BNP浓度依次递增;NYHAⅣ级组和NYHA Ⅲ级组的mDC比例和mDC计数明显低于NYHAⅠ级组和NYHA Ⅱ级组(P<0.05)。结论IL-27和树突状细胞(dendritic cells,DCs)参与了慢性心力衰竭的发生发展。 Objective To investigate the level changes of IL-27 and dendritic cells (DCs) in patients with chronic heart failure. Methods A total of 96 patients with chronic heart failure were enrolled from June 2012 to December 2013 in Zhu- jiang Hospital Affiliated to Southern Medical University and then divided into NYHA Ⅳ group, NYHA m group, NYHA Ⅱ group and NYHA I group according to the New York Heart Association Classification. Heart function were determined by cardiac ultrasound;the ratio and number of DC sub-populations in peripheral blood were determined by flow eytometry;and the levels of IL-27 and B-type natriuretic peptide (BNP) were determined by ELISA. Results The levels of IL-27 were decreasing but BNP were increasing orderly from NYHA Ⅰ group,NYHA Ⅱ group,NYI-IA Ⅲ group and NYHA IV group (P 〈 0. 05). The proportion and count of mDCs were lower in NYHA m group and NYHA Ⅳ group than those in NYHA I group and NYHA Ⅱ group (P 〈 0. 05). Conclusion IL-27 and DCs participate in the development of chronic heart fail-
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第9期888-891,共4页 Chinese Journal of Practical Internal Medicine
基金 国家自然科学基金项目(81202951) 广东省自然科学基金项目(S2012040006782)
关键词 慢性心力衰竭 IL-27 树突状细胞 chronic heart failure IL-27 dendritic cells
  • 相关文献

参考文献12

  • 1Mumgaiyan G,Mittal A,Lopez-Diego R,et al. IL-27 is a key regula- tor of IL-10 and IL-17 production by humen CD4 + T cells[ J]. J Immunol,2009,183 (4) :2435 - 2443.
  • 2王亚静,吴新华.心肌梗死后心力衰竭发生机制的研究进展[J].疑难病杂志,2012,11(9):726-727. 被引量:25
  • 3McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Committee for Practice Guidelines. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 :The Task Force for the Di- agnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC [ J ]. Eur Heart J, 2012,33 (14) :1787 - 1847.
  • 4Leo K, Gabriel Y, Pui-Wai L. Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure [ J ]. International Journal of Cardiology, 2008,125 : 16 - 21.
  • 5Tang TT,Ding YJ,Liao YH,et al. Defective circulating CD4CD25 + Foxp3 + CD127 (low) regulatory T-cells in patients with chronic heart failure [ J ]. Cell Physiol Biochem, 2010,25 ( 4 - 5 ) : 451 - 458.
  • 6Zhu ZF,Li JJ,Liu J,et al. Circulating Thl7 cells are not elevated in patients with chronic heart failure [ J ]. Scand Cardiovasc J ,2012,46 (5) :295 -300.
  • 7Pot C, Jin H, Awasthi A, et al. Cutting edge : IL-27 induces the tran- scription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL- 10-producing Trl ceils[ J]. J Immunol,2009,183 (2) :797 - 801.
  • 8Heath WR, Carbone FIR. Dendritic cell subsets in primary and see- ondary T cell responses at body surfaces [ J ]. Nat Immunol,2009,10 (12) :1237 -12444.
  • 9Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell- development[ J]. Nat Rev Immunol,2007,7 (1) :19 -35.
  • 10Steinman RM. Decisions about dendritic cells:past, present, and future[ J]. AnnuRev Immunol,2012,30 : 1 - 22.

二级参考文献21

  • 1Fedak PW, Verma S, Weisel RD, et al. Cardiac remodeling and failure : from molecules to man[ J]. Cardiovase Patho1,2005,14 (1) :1-11.
  • 2Fichtlscherer S,De Rosa S,Fox H,et al. Circulating microRNAs in patients with coronary artery disease[J]. Circulation Res,2010,107(5) :677-684.
  • 3van Rooij E, Sutherland LB, Qi X, et al. Control of stress-dependent cardiac growth and gene expression by a microRNA[ J]. Science,2007, 316(5824) :575-579.
  • 4Callis TE, Pandya K, Seok HY, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice [ J ]. J Clin Invest, 2009, 119(9) :2772-2786.
  • 5Sabbah HN. Apoptotic cell death in heart failure [ J ]. Cardious Res, 2000,45(3) :704-712.
  • 6Sayed D, He M, Hong C, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotie effects via suppression of fas ligand [ J]. J Biol Chem,2010,285 (26) :20281-20290.
  • 7Cheng Y, Liu X, Zhang S, et al. MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCIM [J]. J Mol Cell Cardio1,2009,47 ( 1 ) :5-14.
  • 8Web CS, Bonnema DD, Ahmed SH, et al. Specific temporal profile of matrix metalloproteinase release occurs in patients after myocardial infarction : relation to left ventricular remodeling [ J ]. Circulation, 2006, 114 (10) : 1020-1027.
  • 9Li M J, Huang CX, Okello E, et al. Treatment with spironolactone for 24 weeks decreases the level of matrix metalloproteinases and improves cardiac function in patients with chronic heart failure of ischemic etiology [J]. Can J Cardiol,2009,25(9) :523-526.
  • 10Morita H, Khanal S, Rastogi S. et al. Selective matrix metalloproteinase inhibition attenuates progression of left vcntricular dysfunction and remodeling in dogs with chronic heart failure [ J ]. Am J Physiol Heart Circ Physio1,2006,290 (6) : H2522-H2527.

共引文献24

同被引文献56

  • 1侯光友,李冰,徐华丽,李少珊.BNP/NT-proBNP在心力衰竭诊断治疗中的应用进展[J].实用医药杂志,2013,30(12):1123-1125. 被引量:13
  • 2无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3698
  • 3Manicassamy S, Pulendran B. Dendritic cell control of tolerogenic responses[J]. Immunol Rev, 2011, 241(1): 206-27.
  • 4Mildner A, Jung S. Development and function of dendritic cell subsets[J]. Immunity, 2014, 40(5): 642-56.
  • 5Kablak-Ziembicka A, Przewlocki T, Sokotowski A, et al. Carotid intima-media thickness, hs-CRP and TNF-α are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease [J]. Atherosclerosis, 2011, 214(1): 185-90.
  • 6Koltsova EK, Ley K. How dendritic cells shape atherosclerosis[J]. Trends Immunol, 2011, 32(11): 540-7.
  • 7Paulson KE, Zhu SN, Chen M, et al. Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis [J]. Circ Res, 2010, 106(2): 383-90.
  • 8Van Vre EA, Van Brussel I, Bosmans JM, et al. Dendritic cells in human atherosclerosis: from circulation to atherosclerotic plaques [J]. Mediators Inflamm, 2011, (8): 941396.
  • 9Yang L, Du CQ, Chen T, et al. Distinct MAPK pathways are involved in IL-23 production in dendritic cells cocultured with NK cells in the absence or presence of angiotensin II[J]. Mol Immunol, 2012, 51(1): 51-6.
  • 10Hochweller K, Sweenie CH, Anderton SM. Immunological tolerance using synthetic peptides-basic mechanisms and clinical application[J]. Curr Mol Med, 2006, 6(6): 631-43.

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部